Possibilities of Predicting Methotrexate-associated Toxicity in Oncohematology Based on Molecular Genetic Testing Methods by Zarui K. Simavonyan, Timur T. Valiev, Marina I. Savelyeva, Sherzod P. Abdullaev, Svetlana R. Varfolomeeva

Subjects: Get full text

Therapeutic drug monitoring vs. pharmacogenetic testing in the context of elevated olanzapine concentrations and prior clozapine intolerability: a case study by Farah Khorassani, Ricardo Azevedo, Reza Farokhpay

Subjects: Get full text

The Influence of CYP2B6, GSTP1, and SLCO1B1 Star Allele‐Predicted Phenotypes and CBR1 Genetic Variants on Effectiveness Outcomes in Patients With Hepatocellular Carcinoma Receiving... by Sireen Abdul Rahim Shilbayeh, Omnia A. Abd El‐Baset, Mohammad A. Alshabeeb, Abdalrhman Hamdan Alanizi, Naglaa F. Khedr, Rehab H. Werida

Subjects: Get full text

Clinical impact of pharmacogenomics in pediatric care: insights extracted from clinical exome sequencing by Simran Maggo, Simran Maggo, Yachen Pan, Dejerianne Ostrow, Jenny Q. Nguyen, Jaclyn A. Biegel, Jaclyn A. Biegel, Matthew A. Deardorff, Matthew A. Deardorff, Xiaowu Gai, Xiaowu Gai, Xiaowu Gai, Xiaowu Gai

Subjects: Get full text

Correction: Clinical impact of pharmacogenomics in pediatric care: insights extracted from clinical exome sequencing by Simran Maggo, Simran Maggo, Yachen Pan, Dejerianne Ostrow, Jenny Q. Nguyen, Jaclyn A. Biegel, Jaclyn A. Biegel, Matthew A. Deardorff, Matthew A. Deardorff, Xiaowu Gai, Xiaowu Gai, Xiaowu Gai, Xiaowu Gai

Subjects: Get full text

Neurotoxicity of high-dose methotrexate in the treatment of non-Hodgkin’s lymphomas in children: clinical and genetic aspects by Z. K. Simavonyan, T. T. Valiev, A. L. Kashanina, V. V. Semenova, A. R. Zheleznyak, L. Serdan Ramos, A. Yu. Ikonnikova, T. V. Nasedkina

Subjects: Get full text

Role of Pharmacogenetic Testing in the Risk and Safety Assessment of Valproates: The Ethnic Aspect (Review) by N. A. Shnayder, V. V. Grechkina, V. V. Arkhipov, R. F. Nasyrova

Subjects: Get full text

Pharmacogenetic testing: current state of the issue by O. V. Kraidashenko, O. O. Kremzer, T. O. Samura

Subjects: Get full text

Patients’ Pharmacogenetic Characteristics and the Risk of Adverse Reactions to Non-steroidal Anti-inflammatory Drugs: Case Reports by A. S. Zhiryakova, N. P. Denisenko, A. V. Kryukov, K. A. Akmalova, S. N. Tuchkova, K. B. Mirzaev, D. A. Sychev

Subjects: Get full text

Pharmacogenetic testing of allelic variants of the CYP2D6 gene in hormone positive breast cancer by L. N. Lyubchenko, M. G. Filippova, T. A. Shendrikova, L. G. Zhukova, N. I. Mekhtieva, O. V. Krokhina, S. M. Portnoy

Subjects: Get full text

CYP2D6-GENOTYPING IN THE ASSESSMENT OF THE EFFECTIVENESS OF THERAPY WITH TAMOXIFEN IN PATIENTS WITH ADVANCED HORMONE RECEPTOR-POSITIVE BREAST CANCER by L. N. Lyubchenko, M. G. Filippova, N. I. Mekhtieva, T. A. Shendrikova, A. V. Semaynikhina, A. V. Snegovoy

Subjects: Get full text

MODERN TECHNOLOGIES IN THERAPEUTIC DRUG MONITORING (REVIEW) by D. A. Abaimov, A. K. Sariev, T. Yu. Noskova, V. V. Shvedkov, M. V. Shiryaeva, E. Yu. Styrova, D. I. Prokhorov, R. D. Seyfulla

Subjects: Get full text